Home / Latest Reports / Ocular Inflammation Treatment Market

Ocular Inflammation Treatment Market By Treatment Type, Disease Type, Mode Of Administration And Distribution Channel - Global Industry Analysis And Forecast To 2023

Published On : May 2022 Pages : 190 Category: Pharmaceuticals Report Code : HC05807

Request Sample Inquiry Before Buying Request for Customization Check Discount

Industry Outlook and Trend Analysis

The Ocular Inflammation Treatment Market was worth USD 22.58 billion in 2017 and is expected to reach approximately USD 39.64 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 6.45% during the forecast period. Expanding pollution of condition by outflow of poisons has raised the dangers of ocular inflammation, otherwise called uveitis. Advancing medical technologies and drug discovery advancements have cleared route for compelling treatment of ocular inflammation.

Drivers and Restraints

Eye inflammations or uveitis are turning into a typical issue for individuals crosswise over the globe. New medications are being found to treat ocular inflammations, and major companies are contributing millions for their endorsement through administrative pipelines. Patients are reflecting a specific inclination to the sort of ocular inflammation treatment being embraced, thinking about the scope of treatment alternatives, their comparative viability, and convenience based on mode of administration. The market for ocular inflammation treatment is foreseen to develop significantly in the following years. Noticeable market players are differentiating their product offerings to provide treatment of all types of uveitis occurring globally.

Market Segmentation

The Ocular Inflammation Treatment Market is segmented into Treatment Type, Disease Type, Mode of Administration and Distribution Channel. Based on treatment type the market is segmented into Corticosteroids, Analgesics, Immunosuppressant, Antivirals, Antibiotics, Monoclonal Antibodies and Antifungal out of which the corticosteroid eye drops are being viewed as the most affordable, convenient and effective treatment for such ocular inflammations. Based on disease type the market is segmented into Posterior Uveitis, Episcleritis/Scleritis, Anterior Uveitis, Pan uveitis and Intermediate Uveitis out of which anterior uveitis is defined by its localization – front of the eye, making it the most preferred form of ocular inflammation. On the basis of mode of administration the market is segmented into injectable, oral and topical. Based on distribution channel the market is divided into online pharmacies, drug stores, retail pharmacies and hospital pharmacies.

Regional Outlook and Trend Analysis

Geographically, the market is segmented into Europe, Asia Pacific, North America and Rest of the world. North America is anticipated to develop significant in the upcoming years owing to supportive government initiatives ad rising awareness regarding ocular inflammations. U.S is foreseen to lay the foundation for the revenue growth of the North America uveitis treatment market.

Competitive Insights

The leading players in the market are Cipla, Valeant Pharmaceuticals, pSivida, Pfizer, AbbVie Inc, Novartis, Akorn, Allergan, Alimera Sciences and EyeGate Pharma. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Ocular Inflammation Treatment market is segmented as follows-

By Treatment Type:

  • Antibiotics
  • Cycloplegic Agents
  • Analgesics
  • Corticosteroids
  • Monoclonal Antibodies
  • Antivirals
  • Immunosuppressant
  • Antifungal

By Disease Type:

  • Intermediate Uveitis
  • Anterior Uveitis
  • Pan uveitis
  • Episcleritis/Scleritis
  • Posterior Uveitis

By Mode of Administration:

  • Injectable
  • Oral
  • Topical
  • Others

By Distribution Channel:

  • Retail Pharmacies
  • Drug Stores
  • Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America

 

  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2023?
  • What will be the industry market growth from 2017 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Ocular Inflammation Treatment Market, By Treatment Type, Estimates and Forecast, 2014-2023 ($Million)

·         Corticosteroids

·         Antibiotics

·         Monoclonal Antibodies

·         Cycloplegic Agents     

·         Immunosuppressant

·         Antivirals

·         Analgesics

·         Antifungal

·         Ocular Inflammation Treatment Market, By Disease Type, Estimates and Forecast, 2014-2023 ($Million)

·         Anterior Uveitis

·         Posterior Uveitis

·         Pan uveitis

·         Intermediate Uveitis

·         Episcleritis/Scleritis

·         Ocular Inflammation Treatment Market, By Mode of Administration, Estimates and Forecast, 2014-2023 ($Million)

·         Topical

·         Injectable

·         Oral

·         Other Modes of Administration

·         Ocular Inflammation Treatment Market, By Distribution Channel, Estimates and Forecast, 2014-2023 ($Million)

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

·         Drug Stores

·         Ocular Inflammation Treatment Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

o    North America

§  North America Ocular Inflammation Treatment Market, By Country

o    U.S. Ocular Inflammation Treatment Market

o    Canada Ocular Inflammation Treatment Market

o    Mexico Ocular Inflammation Treatment Market

o    Europe

§  Europe Ocular Inflammation Treatment Market, By Country

o    Germany Ocular Inflammation Treatment Market

o    UK Ocular Inflammation Treatment Market

o    France Ocular Inflammation Treatment Market

o    Russia Ocular Inflammation Treatment Market

o    Italy Ocular Inflammation Treatment Market

o    Rest of Europe Ocular Inflammation Treatment Market

o    Asia-Pacific

§  Asia-Pacific Ocular Inflammation Treatment Market, By Country

o    China Ocular Inflammation Treatment Market

o    Japan Ocular Inflammation Treatment Market

o    South Korea Ocular Inflammation Treatment Market

o    India Ocular Inflammation Treatment Market

o    Southeast Asia Ocular Inflammation Treatment Market

o    Rest of Asia-Pacific Ocular Inflammation Treatment Market

o    South America

§  South America Ocular Inflammation Treatment Market

o    Brazil Ocular Inflammation Treatment Market

o    Argentina Ocular Inflammation Treatment Market

o    Columbia Ocular Inflammation Treatment Market

o    South Africa Ocular Inflammation Treatment Market

o    Rest of South America Ocular Inflammation Treatment Market

o    Middle East and Africa

§  Middle East and Africa Ocular Inflammation Treatment Market

o    Saudi Arabia Ocular Inflammation Treatment Market

o    UAE Ocular Inflammation Treatment Market

o    Egypt Ocular Inflammation Treatment Market

o    Nigeria Ocular Inflammation Treatment Market

o    South Africa Ocular Inflammation Treatment Market

o    Rest of MEA Ocular Inflammation Treatment Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Ocular Inflammation Treatment Market, By Treatment Type

5.1.       Introduction

5.2.       Global Ocular Inflammation Treatment Sales, Revenue and Market Share by Treatment Type (2017-2027)

5.2.1.  Global Ocular Inflammation Treatment Sales and Sales Share by Treatment Type (2017-2027)

5.2.2.  Global Ocular Inflammation Treatment Revenue and Revenue Share by Treatment Type (2017-2027)

5.3.       Corticosteroids

5.3.1.  Global Corticosteroids Sales and Growth Rate (2017-2027)

5.4.       Antibiotics

5.4.1.  Global Antibiotics Sales and Growth Rate (2017-2027)

5.5.       Monoclonal Antibodies

5.5.1.  Global Monoclonal Antibodies Sales and Growth Rate (2017-2027)

5.6.       Immunosuppressant

5.6.1.  Global Immunosuppressant Sales and Growth Rate (2017-2027)

5.7.       Cycloplegic Agents

5.7.1.  Global Cycloplegic Agents Sales and Growth Rate (2017-2027)

5.8.       Antivirals

5.8.1.  Global Antivirals Sales and Growth Rate (2017-2027)

5.9.       Antifungal

5.9.1.  Global Antifungal Sales and Growth Rate (2017-2027)

5.10.    Analgesics

5.10.1.      Global Analgesics Sales and Growth Rate (2017-2027)

6.       Ocular Inflammation Treatment Market, By Disease Type

6.1.       Introduction

6.2.       Global Ocular Inflammation Treatment Sales, Revenue and Market Share by Disease Type (2017-2027)

6.2.1.  Global Ocular Inflammation Treatment Sales and Sales Share by Disease Type (2017-2027)

6.2.2.  Global Ocular Inflammation Treatment Revenue and Revenue Share by Disease Type (2017-2027)

6.3.       Anterior Uveitis

6.3.1.  Global Anterior Uveitis Sales and Growth Rate (2017-2027)

6.4.       Posterior Uveitis

6.4.1.  Global Posterior Uveitis Sales and Growth Rate (2017-2027)

6.5.       Pan uveitis

6.5.1.  Global Pan uveitis Sales and Growth Rate (2017-2027)

6.6.       Intermediate Uveitis

6.6.1.  Global Intermediate Uveitis Sales and Growth Rate (2017-2027)

6.7.       Episcleritis/Scleritis

6.7.1.  Global Episcleritis/Scleritis Sales and Growth Rate (2017-2027)

7.       Ocular Inflammation Treatment Market, By Mode of Administration

7.1.       Introduction

7.2.       Global Ocular Inflammation Treatment Sales, Revenue and Market Share by Mode of Administration (2017-2027)

7.2.1.  Global Ocular Inflammation Treatment Sales and Sales Share by Mode of Administration (2017-2027)

7.2.2.  Global Ocular Inflammation Treatment Revenue and Revenue Share by Mode of Administration (2017-2027)

7.3.       Topical

7.3.1.  Global Topical Sales and Growth Rate (2017-2027)

7.4.       Injectable

7.4.1.  Global Injectable Sales and Growth Rate (2017-2027)

7.5.       Oral

7.5.1.  Global Oral Sales and Growth Rate (2017-2027)

7.6.       Other Modes of Administration

7.6.1.  Global Other Modes of Administration Sales and Growth Rate (2017-2027)

8.       Ocular Inflammation Treatment Market, By Distribution Channel

8.1.       Introduction

8.2.       Global Ocular Inflammation Treatment Sales, Revenue and Market Share by Distribution Channel (2017-2027)

8.2.1.  Global Ocular Inflammation Treatment Sales and Sales Share by Distribution Channel (2017-2027)

8.2.2.  Global Ocular Inflammation Treatment Revenue and Revenue Share by Distribution Channel (2017-2027)

8.3.       Hospital Pharmacies

8.3.1.  Global Hospital Pharmacies Sales and Growth Rate (2017-2027)

8.4.       Retail Pharmacies

8.4.1.  Global Retail Pharmacies Sales and Growth Rate (2017-2027)

8.5.       Online Pharmacies

8.5.1.  Global Online Pharmacies Sales and Growth Rate (2017-2027)

8.6.       Drug Stores

8.6.1.  Global Drug Stores Sales and Growth Rate (2017-2027)

9.       Ocular Inflammation Treatment Market, By Region

9.1.       Introduction

9.2.       Global Ocular Inflammation Treatment Sales, Revenue and Market Share by Regions

9.2.1.  Global Ocular Inflammation Treatment Sales by Regions (2017-2027)

9.2.2.  Global Ocular Inflammation Treatment Revenue by Regions (2017-2027)

9.3.       North America Ocular Inflammation Treatment by Countries

9.3.1.  North America Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.3.2.  North America Ocular Inflammation Treatment Revenue and Growth Rate (2017-2027)

9.3.3.  North America Ocular Inflammation Treatment Sales by Countries (2017-2027)

9.3.4.  North America Ocular Inflammation Treatment Revenue (Million USD) by Countries (2017-2027)

9.3.5.  U.S.

9.3.5.1.    United States Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.3.5.2.    United States Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.6.  Canada

9.3.6.1.    Canada Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.3.6.2.    Canada Ocular Inflammation Treatment Sales (Millions USD) and Growth Rate (2017-2027)

9.3.7.  Mexico

9.3.7.1.    Mexico Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.3.7.2.    Mexico Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.       Europe Ocular Inflammation Treatment by Countries

9.4.1.  Europe Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.4.2.  Europe Ocular Inflammation Treatment Revenue and Growth Rate (2017-2027)

9.4.3.  Europe Ocular Inflammation Treatment Sales by Countries (2017-2027)

9.4.4.  Europe Ocular Inflammation Treatment Revenue (Million USD) by Countries (2017-2027)

9.4.5.  Germany

9.4.5.1.    Germany Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.4.5.2.    Germany Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  UK

9.4.6.1.    UK Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.4.6.2.    UK Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  France

9.4.7.1.    France Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.4.7.2.    France Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Russia

9.4.8.1.    Russia Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.4.8.2.    Russia Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.9.  Italy

9.4.9.1.    Italy Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.4.9.2.    Italy Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.10.      Rest of Europe

9.4.10.1. Rest of Europe Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.4.10.2. Rest of Europe Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.       Asia-Pacific

9.5.1.  Asia-Pacific Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Ocular Inflammation Treatment Revenue and Growth Rate (2017-2027)

9.5.3.  Asia-Pacific Ocular Inflammation Treatment Sales by Countries (2017-2027)

9.5.4.  Asia-Pacific Ocular Inflammation Treatment Revenue (Million USD) by Countries (2017-2027)

9.5.5.  China

9.5.5.1.    China Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.5.5.2.    China Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  Japan

9.5.6.1.    Japan Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.5.6.2.    Japan Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.3.     

9.5.7.  Korea

9.5.7.1.    Korea Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.5.7.2.    Korea Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  India

9.5.8.1.    India Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.5.8.2.    India Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.9.  Southeast Asia

9.5.9.1.    Southeast Asia Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.5.9.2.    Southeast Asia Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.10.      Rest of Asia-Pacific

9.5.10.1. Rest of Asia-Pacific Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.5.10.2. Rest of Asia-Pacific Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.       South America

9.6.1.  South America Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.6.2.  South America Ocular Inflammation Treatment Revenue and Growth Rate (2017-2027)

9.6.3.  South America Ocular Inflammation Treatment Sales by Countries (2017-2027)

9.6.4.  South America Ocular Inflammation Treatment Revenue (Million USD) by Countries (2017-2027)

9.6.5.  Brazil

9.6.5.1.    Brazil Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.6.5.2.    Brazil Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Argentina

9.6.6.1.    Argentina Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.6.6.2.    Argentina Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.7.  Columbia

9.6.7.1.    Columbia Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.6.7.2.    Columbia Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.8.  Rest of South America

9.6.8.1.    Rest of South America Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.6.8.2.    Rest of South America Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.       Middle East and Africa

9.7.1.  Middle East and Africa Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Ocular Inflammation Treatment Revenue and Growth Rate (2017-2027)

9.7.3.  Middle East and Africa Ocular Inflammation Treatment Sales by Countries (2017-2027)

9.7.4.  Middle East and Africa Ocular Inflammation Treatment Revenue (Million USD) by Countries (2017-2027)

9.7.5.  Saudi Arabia

9.7.5.1.    Saudi Arabia Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.7.5.2.    Saudi Arabia Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  United Arab Emirates

9.7.6.1.    United Arab Emirates Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.7.6.2.    United Arab Emirates Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  Egypt

9.7.7.1.    Egypt Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.7.7.2.    Egypt Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Nigeria

9.7.8.1.    Nigeria Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.7.8.2.    Nigeria Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.9.  South Africa

9.7.9.1.    South Africa Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.7.9.2.    South Africa Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.10.      Rest of Middle East and Africa

9.7.10.1. Rest of Middle East and Africa Ocular Inflammation Treatment Sales and Growth Rate (2017-2027)

9.7.10.2. Rest of Middle East and Africa Ocular Inflammation Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

10.   Company Profiles

10.1.      Allergan Plc

10.1.1.      Business Overview

10.1.2.      Product Portfolio

10.1.3.      Strategic Developments

10.1.4.      Sales, Revenue and Market Share

10.2.    Valeant Pharmaceuticals International, Inc.

10.2.1.      Business Overview

10.2.2.      Product Portfolio

10.2.3.      Strategic Developments

10.2.4.      Sales, Revenue and Market Share

10.3.    Novartis AG

10.3.1.      Business Overview

10.3.2.      Product Portfolio

10.3.3.      Strategic Developments

10.3.4.      Sales, Revenue and Market Share

10.4.    Abbvie, Inc.

10.4.1.      Business Overview

10.4.2.      Product Portfolio

10.4.3.      Strategic Developments

10.4.4.      Sales, Revenue and Market Share

10.5.    Pfizer, Inc.

10.5.1.      Business Overview

10.5.2.      Product Portfolio

10.5.3.      Strategic Developments

10.5.4.      Sales, Revenue and Market Share

10.6.    Cipla Ltd.

10.6.1.      Business Overview

10.6.2.      Product Portfolio

10.6.3.      Strategic Developments

10.6.4.      Sales, Revenue and Market Share

10.7.     Akorn, Inc.

10.7.1.      Business Overview

10.7.2.      Product Portfolio

10.7.3.      Strategic Developments

10.7.4.      Sales, Revenue and Market Share

10.8.    Eyegate Pharmaceuticals, Inc.

10.8.1.      Business Overview

10.8.2.      Product Portfolio

10.8.3.      Strategic Developments

10.8.4.      Sales, Revenue and Market Share

10.9.    Alimera Sciences, Inc.

10.9.1.      Business Overview

10.9.2.      Product Portfolio

10.9.3.      Strategic Developments

10.9.4.      Sales, Revenue and Market Share

10.10.pSivida Corporation

10.10.1.  Business Overview

10.10.2.  Product Portfolio

10.10.3.  Strategic Developments

10.10.4.  Sales, Revenue and Market Share

11.   Global Ocular Inflammation Treatment Market Competition, by Manufacturer

11.1.    Global Ocular Inflammation Treatment Sales and Market Share by Manufacturer (2017-2017)

11.2.    Global Ocular Inflammation Treatment Revenue and Market Share by Manufacturer (2017-2017)

11.3.    Global Ocular Inflammation Treatment Price by Manufacturer (2017-2017)

11.4.    Top 5 Ocular Inflammation Treatment Manufacturer Market Share

11.5.    Market Competition Trend

12.   Ocular Inflammation Treatment Market Forecast (2027-2023)

12.1.    Global Ocular Inflammation Treatment Sales, Revenue (Millions USD) and Growth Rate (2027-2023)

12.2.    Ocular Inflammation Treatment Market Forecast by Regions (2027-2023)

12.2.1.      North America Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.1.1. United States Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.1.2. Canada Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.1.3. Mexico Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.2.      Europe Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.2.1. Germany Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.2.2. United Kingdom Ocular Inflammation Treatments Market Forecast (2027-2023)

12.2.2.3. France Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.2.4. Russia Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.2.5. Italy Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.2.6. Rest of the Europe Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.3.      Asia-Pacific Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.3.1. China Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.3.2. Japan Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.3.3. Korea Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.3.4. India Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.3.5. Southeast Asia Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.3.6. Rest of Asia-Pacific Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.4.      South America Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.4.1. Brazil Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.4.2. Argentina Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.4.3. Columbia Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.4.4. Rest of South America Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.5.      Middle East and Africa Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.5.1. Saudi Arabia Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.5.2. UAE Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.5.3. Egypt Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.5.4. Nigeria Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.5.5. South Africa Ocular Inflammation Treatment Market Forecast (2027-2023)

12.2.5.6. Rest of MEA Ocular Inflammation Treatment Market Forecast (2027-2023)

12.3.    Ocular Inflammation Treatment Market Forecast by Treatment Type (2027-2023)

12.3.1.      Global Ocular Inflammation Treatment Sales Forecast by Treatment Type (2027-2023)

12.3.2.      Global Ocular Inflammation Treatment Sales Market Share Forecast by Treatment Type (2027-2023)

12.4.    Ocular Inflammation Treatment Market Forecast by Disease Type (2027-2023)

12.4.1.      Global Ocular Inflammation Treatment Sales Forecast by Disease Type (2027-2023)

12.4.2.      Global Ocular Inflammation Treatment Sales Market Share Forecast by Disease Type (2027-2023)

12.5.    Ocular Inflammation Treatment Market Forecast by Mode of Administration (2027-2023)

12.5.1.      Global Ocular Inflammation Treatment Sales Forecast by Mode of Administration (2027-2023)

12.5.2.      Global Ocular Inflammation Treatment Sales Market Share Forecast by Mode of Administration (2027-2023)

12.6.      Ocular Inflammation Treatment Market Forecast by Distribution Channel (2027-2023)

12.6.1.      Global Ocular Inflammation Treatment Sales Forecast by Distribution Channel (2027-2023)

12.6.2.      Global Ocular Inflammation Treatment Sales Market Share Forecast by Distribution Channel (2027-2023)

 

 

 

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Ocular Inflammation Treatment Market.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*